{
    "2019-09-02": [
        [
            {
                "time": "",
                "original_text": "4+7带量采购正式全国扩围 如何影响产业链 哪些公司有望受益？",
                "features": {
                    "keywords": [
                        "4+7带量采购",
                        "全国扩围",
                        "产业链",
                        "公司受益"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药上半年主营业务毛利率普降，销售费用十倍于研发费用 盈利能力下降",
                "features": {
                    "keywords": [
                        "上海医药",
                        "毛利率下降",
                        "销售费用",
                        "研发费用",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【上海医药】19年中报：工商继续协同发力，现金流改善明显",
                "features": {
                    "keywords": [
                        "上海医药",
                        "中报",
                        "现金流改善",
                        "协同发力"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "广州白云山等3家药企入选2019中国企业可持续发展100佳",
                "features": {
                    "keywords": [
                        "广州白云山",
                        "可持续发展",
                        "药企入选"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药:工商齐发力,业绩稳健增长",
                "features": {
                    "keywords": [
                        "上海医药",
                        "工商齐发力",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}